Viewing Study NCT01239394


Ignite Creation Date: 2025-12-25 @ 1:28 AM
Ignite Modification Date: 2026-01-04 @ 12:55 AM
Study NCT ID: NCT01239394
Status: COMPLETED
Last Update Posted: 2017-10-18
First Post: 2010-11-10
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Ofatumumab for Initial Systemic Treatment of Indolent B-cell Lymphoma
Sponsor: Massachusetts General Hospital
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Follicular Lymphoma View
None Marginal Zone Lymphoma View
None Small Lymphocytic Lymphoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None NHL View
None ofatumumab View